Use of 99mTc-doxorubicin scintigraphy in females with breast cancer: a pilot study

摘要

Objective:Doxorubicin (Eurofarma, São Paulo, Brazil) is an antitumour agent widely used in the treatment of breast cancer and can be used for tumour tracking when labelled with a radionuclide. Here, we present the results obtained with technetium-99m (^99mTc)-doxorubicin, using the direct method, to evaluate its uptake in breast cancer.